Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3388)
All Articles published online
|
Feb 7, 2006 (publication date) through Dec 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jin T, Nakatani H, Taguchi T, Nakano T, Okabayashi T, Sugimoto T, Kobayashi M, Araki K. STI571 (Glivec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1. World J Gastroenterol 2006; 12(5): 703-708 [PMID: 16521182 DOI: 10.3748/wjg.v12.i5.703] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i5/703.htm |
| Number | Citing Articles |
| 1 |
Toshiyuki Nakayama, Yang Cheul Cho, Yuka Mine, Ayumi Yoshizaki, Shinji Naito, Chun Yang Wen, Ichiro Sekine. Expression of vascular endothelial growth factor and its receptors VEGFR-1 and 2 in gastrointestinal stromal tumors, leiomyomas and schwannomas. World Journal of Gastroenterology 2006; 12(38): 6182-6187 doi: 10.3748/wjg.v12.i38.6182
|
| 2 |
Ying Huang, Fan Li, Weidong Tong, Anping Zhang, Yujun He, Tao Fu, Baohua Liu. Hydrogen Sulfide, a Gaseous Transmitter, Stimulates Proliferation of Interstitial Cells of Cajal via Phosphorylation of AKT Protein Kinase. The Tohoku Journal of Experimental Medicine 2010; 221(2): 125 doi: 10.1620/tjem.221.125
|
| 3 |
Panagiotis Tsagozis, Jordi Gonzalez-Molina, Anna-Maria Georgoudaki, Kaisa Lehti, Joseph Carlson, Andreas Lundqvist, Felix Haglund, Monika Ehnman. Tumor Microenvironments in Organs. Advances in Experimental Medicine and Biology 2020; 1296: 319 doi: 10.1007/978-3-030-59038-3_20
|
| 4 |
F. Berger, M. Reiser. Neue bildgebende Strategien zum Monitoring molekularer Pharmakotherapien bei GIST. Der Radiologe 2008; 48(9): 832 doi: 10.1007/s00117-008-1740-8
|
| 5 |
Mona-Elisabeth Revheim, Knut Håkon Hole, Øyvind Sverre Bruland, Edmund Reitan, Bodil Bjerkehagen, Lars Julsrud, Therese Seierstad. Multimodal functional imaging for early response assessment in GIST patients treated with imatinib. Acta Oncologica 2014; 53(1): 143 doi: 10.3109/0284186X.2013.798428
|
| 6 |
John C. McAuliffe, Alexander J.F. Lazar, Dan Yang, Dejka M. Steinert, Wei Qiao, Peter F. Thall, A. Kevin Raymond, Robert S. Benjamin, Jonathan C. Trent. Association of Intratumoral Vascular Endothelial Growth Factor Expression and Clinical Outcome for Patients with Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate. Clinical Cancer Research 2007; 13(22): 6727 doi: 10.1158/1078-0432.CCR-07-0895
|
| 7 |
Yvonne M.H. Versleijen-Jonkers, Myrella Vlenterie, Addy C.M. van de Luijtgaarden, Winette T.A. van der Graaf. Anti-angiogenic therapy, a new player in the field of sarcoma treatment. Critical Reviews in Oncology/Hematology 2014; 91(2): 172 doi: 10.1016/j.critrevonc.2014.02.001
|
| 8 |
F. Berger, E.C. Winkler, C. Ruderer, M.F. Reiser. Moderne bildgebende Diagnostik bei Weichteilsarkomen. Der Chirurg 2009; 80(3): 175 doi: 10.1007/s00104-008-1594-7
|
| 9 |
Siyue Du, Nicole Wagner, Kay-Dietrich Wagner. The Emerging Role of PPAR Beta/Delta in Tumor Angiogenesis. PPAR Research 2020; 2020: 1 doi: 10.1155/2020/3608315
|
| 10 |
Alex Kiselyov, Konstantin V Balakin, Sergey E Tkachenko. VEGF/VEGFR signalling as a target for inhibiting angiogenesis. Expert Opinion on Investigational Drugs 2007; 16(1): 83 doi: 10.1517/13543784.16.1.83
|
| 11 |
Rosario S. Rivera, Hitoshi Nagatsuka, Mehmet Gunduz, Beyhan Cengiz, Esra Gunduz, Chong Huat Siar, Hidetsugu Tsujigiwa, Ryo Tamamura, Kok Ng Han, Noriyuki Nagai. C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma. Virchows Archiv 2008; 452(1): 27 doi: 10.1007/s00428-007-0524-2
|
| 12 |
Sergei Boichuk, Pavel Dunaev, Aigul Galembikova, Elena Valeeva. Fibroblast Growth Factor 2 (FGF2) Activates Vascular Endothelial Growth Factor (VEGF) Signaling in Gastrointestinal Stromal Tumors (GIST): An Autocrine Mechanism Contributing to Imatinib Mesylate (IM) Resistance. Cancers 2024; 16(17): 3103 doi: 10.3390/cancers16173103
|
| 13 |
Alexander S. Kiselyov, Marina Semenova, Victor V. Semenov. 3,4-Disubstituted isothiazoles: Novel potent inhibitors of VEGF receptors 1 and 2. Bioorganic & Medicinal Chemistry Letters 2009; 19(4): 1195 doi: 10.1016/j.bmcl.2008.12.078
|
| 14 |
T. B. Wang, W. S. Qiu, B. Wei, M. H. Deng, H. B. Wei, W. G. Dong. Serum vascular endothelial growth factor and angiogenesis are related to the prognosis of patients with gastrointestinal stromal tumors. Irish Journal of Medical Science 2009; 178(3): 315 doi: 10.1007/s11845-009-0315-7
|
| 15 |
N. Schramm, E. Englhart, M. Schlemmer, M. Hittinger, C. Übleis, C.R. Becker, M.F. Reiser, F. Berger. Tumor response and clinical outcome in metastatic gastrointestinal stromal tumors under sunitinib therapy: Comparison of RECIST, Choi and volumetric criteria. European Journal of Radiology 2013; 82(6): 951 doi: 10.1016/j.ejrad.2013.02.034
|
| 16 |
Ylva. A. Weeda, Gijsbert M. Kalisvaart, Floris H. P. van Velden, Hans Gelderblom, Aart. J. van der Molen, Judith V. M. G. Bovee, Jos A. van der Hage, Willem Grootjans, Lioe-Fee de Geus-Oei. Early Prediction and Monitoring of Treatment Response in Gastrointestinal Stromal Tumors by Means of Imaging: A Systematic Review. Diagnostics 2022; 12(11): 2722 doi: 10.3390/diagnostics12112722
|
| 17 |
Feng Pan, Jie Den, Chunfang Zhang, He Wang, Jin Cheng, Weizhen Wu, Nan Hong, Yi Wang, Gayle E. Woloschak. The Therapeutic Response of Gastrointestinal Stromal Tumors to Imatinib Treatment Assessed by Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging with Histopathological Correlation. PLOS ONE 2016; 11(12): e0167720 doi: 10.1371/journal.pone.0167720
|
| 18 |
Alexander S. Kiselyov, Marina Semenova, Victor V. Semenov. (1,2,3-Triazol-4-yl)benzenamines: Synthesis and activity against VEGF receptors 1 and 2. Bioorganic & Medicinal Chemistry Letters 2009; 19(5): 1344 doi: 10.1016/j.bmcl.2009.01.046
|
| 19 |
Sridurga Mithraprabhu, Kate L Loveland. Control of KIT signalling in male germ cells: what can we learn from other systems?. REPRODUCTION 2009; 138(5): 743 doi: 10.1530/REP-08-0537
|
| 20 |
Marcus Schlemmer, Steven P. Sourbron, Nicole Schinwald, Konstantin Nikolaou, Christoph R. Becker, Maximilian F. Reiser, Frank Berger. Perfusion patterns of metastatic gastrointestinal stromal tumor lesions under specific molecular therapy. European Journal of Radiology 2011; 77(2): 312 doi: 10.1016/j.ejrad.2009.07.031
|
| 21 |
Masakazu Imamura, Hidetaka Yamamoto, Norimoto Nakamura, Yoshinao Oda, Takashi Yao, Yoshihiro Kakeji, Hideo Baba, Yoshihiko Maehara, Masazumi Tsuneyoshi. Prognostic significance of angiogenesis in gastrointestinal stromal tumor. Modern Pathology 2007; 20(5): 529 doi: 10.1038/modpathol.3800767
|
| 22 |
Hajime Nakatani, Toyokazu Akimori, Yuka Takezaki, Kazuhiro Hanazaki. Vascular endothelial growth factors and their receptors in the novel human cell line, HN-Eso-1, established from esophageal spindle cell carcinoma. The Journal of Medical Investigation 2010; 57(3,4): 232 doi: 10.2152/jmi.57.232
|
| 23 |
Bilge Can, Filiz Karagoz, Levent Yildiz, Arzu Yildirim, Mehmet Kefeli, Guzin Gonullu, Bedri Kandemir. Thymosin β4 is a novel potential prognostic marker in gastrointestinal stromal tumors. APMIS 2012; 120(9): 689 doi: 10.1111/j.1600-0463.2012.02887.x
|
| 24 |
Tian-bao Wang, Xiu-qing Wei, Wei-hao Lin, Han-ping Shi, Wen-guang Dong. The inhibition of Endostar on the angiogenesis and growth of gastrointestinal stromal tumor xenograft. Clinical and Experimental Medicine 2012; 12(2): 89 doi: 10.1007/s10238-011-0143-8
|